Puyod, Generoso A.
HRN: 15-27-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2023
CEFUROXIME 1.5GM (VIAL)
03/13/2023
03/20/2023
IV
1.5gm
Q8
Lacerated Wounds
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes